Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIBRINOGENE T1 for peri-operative bleeding in revision total hip arthroplasty
2008-007110-29Phase 2Active
- Sponsor
- LFB Group
- Start
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Fibrinogen human in Bleeding (3 arms), sponsored by LFB Group. Primary endpoint: Peri-operative blood loss volume. Started Mar 2009; status: active.
02
Drugs
Fibrinogen human
03
Conditions
Bleeding
Beyond the preview
Go deeper on 2008-007110-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007110-29.